Skip to content

Understanding tiredness during Guillain-Barr recovery.

Fatigue severity across recovery stages in individuals with Guillain-Barr syndrome-An exploratory study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108372
Enrollment
33
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G610- Guillain-Barre syndrome

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Gizelle Pereira
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with GBS 2. Age: 18-65 years 3. Patients in the acute phase of GBS (less than 2 week onset) 4. Intact cognition (MoCA more than equal to 26) 5. Functional communication (ability to speak or encircle or point out the number on the scale) to respond to fatigue assessment

Exclusion criteria

Exclusion criteria: 1. Pre-existing chronic fatigue syndrome or medical conditions causing fatigue (e.g., uncontrolled hypothyroidism, anemia, chronic kidney or liver disease) 2. Presence of other neurological disorders 3. History of psychiatric disorders or moderate to severe depression 4. Patients requiring prolonged mechanical ventilation (more than 2 weeks) preventing assessment of fatigue in the acute phase

Design outcomes

Primary

MeasureTime frame
The outcome of this study is to explore the differences in severity of fatigue scores across three stages of recovery in individuals with Guillain-Barr syndrome.Timepoint: 3 time points Acute phase - less than 2 weeks post onset Initial recovery phase - 3rd to 8th week Late recovery phase - 9th to 12th week

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Apoorva M Shankaranarayana

Manipal College of Health Professions

mani.kandan@manipal.edu8202922533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026